Production (Stage)
GRI Bio, Inc.
GRI
$1.36
$0.064.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -40.38% | -45.23% | -50.79% | -40.27% | 201.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 100.00% | -- | -- |
| Total Operating Expenses | -22.02% | -26.05% | -22.92% | -4.65% | 297.49% |
| Operating Income | 22.02% | 26.05% | 22.92% | 4.65% | -297.49% |
| Income Before Tax | -3.54% | 7.44% | 37.87% | 28.12% | -152.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.54% | 7.44% | 37.87% | 28.12% | -152.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.54% | 7.44% | 37.87% | 28.12% | -152.20% |
| EBIT | 22.02% | 26.05% | 22.92% | 4.65% | -297.49% |
| EBITDA | 22.03% | 26.06% | 22.93% | 4.65% | -297.75% |
| EPS Basic | 76.30% | 57.18% | 36.83% | -5.89% | -52.92% |
| Normalized Basic EPS | -3.61% | -- | -- | -- | -- |
| EPS Diluted | 74.58% | 55.53% | 36.83% | -5.89% | -52.92% |
| Normalized Diluted EPS | -3.61% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 6,473.26% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 1,583.84% | 897.93% | 255.05% | 20.83% | 12.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |